首页> 外文期刊>Human Genetics >Hierarchical fine mapping of the cystic fibrosis modifier locus on 19q13 identifies an association with two elements near the genes CEACAM3 and CEACAM6
【24h】

Hierarchical fine mapping of the cystic fibrosis modifier locus on 19q13 identifies an association with two elements near the genes CEACAM3 and CEACAM6

机译:囊性纤维化修饰基因座在19q13上的分层精细定位可确定与CEACAM3和CEACAM6基因附近的两个元素相关

获取原文
获取原文并翻译 | 示例
           

摘要

On 19q13, TGFB1 and the cystic fibrosis modifier 1 locus (CFM1) have been identified as modifiers of the course of the monogenic disease cystic fibrosis (CF). Recently, we have described a transmission disequilibrium at the microsatellite D19S197, localized between TGFB1 and CFM1. To map the corresponding molecular variants, we have selected informative SNP markers within a 600-kb area and compared two-marker-haplotype-distributions between phenotypically contrasting sib pair groups, intending to type only phylogenetically old markers by aiming for close-to-maximal polymorphism information content of the SNPs. Starting with a seed set of five SNPs that cover intermarker distances of up to 50 kb, we have iteratively added more SNPs to the map, until we could identify two genomic fragments of 3,289 and 2,052 bp for which pairs with contrasting phenotypes showed different haplotype distributions on the final 17-SNP-map (P raw = 0.0002, P corr17SNPs = 0.0106 and P raw = 0.0008, P corr17SNPs = 0.0469, respectively). Resequencing of these fragments of four unrelated individuals for each element showed that the mildly and severely affected pairs differ in seven SNPs and concordant pairs differ from discordant pairs in five SNPs. Annotation of these variants indicate that CEACAM6 and a regulatory element near the 3′ end of CEACAM3 are associated with CF disease severity and intrapair discordance, respectively. While our approach was only guided by the markers’ position, the involvement of genes from the CEACAM family in host defense and innate immunity designates these proteins as likely modifiers of the multi-organ disease cystic fibrosis which is known for its cytokine imbalance and pro-inflammatory phenotype.
机译:在19q13,TGFB1和囊性纤维化调节剂1位点(CFM1)已被鉴定为单基因疾病囊性纤维化(CF)病程的调节剂。最近,我们已经描述了位于TGFB1和CFM1之间的微卫星D19S197的传输不平衡。为了绘制相应的分子变体,我们在600kb的区域内选择了有信息价值的SNP标记,并比较了表型相反的同胞对组之间的两个标记单倍型分布,目的是通过接近系统最大的标记来仅分类系统发育上的旧标记。 SNP的多态性信息含量。从五个覆盖最大标记间距离的SNP的种子集开始,我们将更多SNP迭代添加到图谱中,直到我们可以识别出3289和2052 bp的两个基因组片段,其中具有相反表型的对显示不同的单倍型分布在最终的17-SNP图上(P raw = 0.0002,P corr17SNPs = 0.0106和P raw = 0.0008,P corr17SNPs = 0.0469)。对每个元素的四个无关个体的这些片段进行重新测序表明,轻度和重度感染对在七个SNP中有所不同,而一致对则在五个SNP中与不和谐对不同。这些变体的注释表明,CEACAM6和CEACAM3 3'端附近的调控元件分别与CF疾病严重程度和配对对不一致有关。尽管我们的方法仅受标记物位置的指导,但来自CEACAM家族的基因参与宿主防御和先天性免疫后,这些蛋白质被指定为多器官疾病性囊性纤维化的可能修饰物,该病因其细胞因子失衡和促凋亡作用而闻名。炎性表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号